These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6195455)

  • 1. Comparison of prizidilol, a new antihypertensive drug with combined arteriolar vasodilator and beta-adrenoceptor blocking actions, with hydralazine and propranolol in conscious dogs with chronic atrioventricular block.
    Boucher M; Dubray C; Duchêne-Marullaz P
    J Cardiovasc Pharmacol; 1983; 5(5):712-6. PubMed ID: 6195455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the mechanism of the acute antihypertensive and vasodilator actions of several beta-adrenoceptor antagonists.
    Sybertz EJ; Baum T; Pula KK; Nelson S; Eynon E; Sabin C
    J Cardiovasc Pharmacol; 1982; 4(5):749-58. PubMed ID: 6182405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic and pharmacokinetic studies on prizidilol and nipradilol (K-351), antihypertensive drugs with combined vasodilator and beta-adrenoceptor blocking actions, in rabbits.
    Kawashima K; Watanabe TX; Sokabe H
    Jpn J Pharmacol; 1984 Dec; 36(4):519-26. PubMed ID: 6151998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of prizidilol hydrochloride (SK & F 92657), a new antihypertensive agent with beta-adrenoceptor antagonist and vasodilator activity with propranolol and hydralazine in normal volunteers.
    Steiner JA; Clancy A; Manghani KK; James IM
    Br J Clin Pharmacol; 1981 Oct; 12(4):573-8. PubMed ID: 6117309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An assessment of beta-adrenoceptor blockade in man by prizidilol hydrochloride.
    Pitcher DW; Curry PV; Trounce JR
    Br J Clin Pharmacol; 1982 May; 13(5):711-6. PubMed ID: 6123343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary effects in man of oral prizidilol hydrochloride (SK&F 92657), a new antihypertensive agent.
    Edmondstone WM; Waller JF; Manghani KK; Hill PL; Bell AJ; Denison DM
    Br J Clin Pharmacol; 1983 Dec; 16(6):591-8. PubMed ID: 6140939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the stereoisomers of beta-adrenoceptor antagonists in conscious A-V blocked dogs.
    Boucher M; Duchêne-Marullaz P; Moundanga JL
    Br J Pharmacol; 1986 Sep; 89(1):119-27. PubMed ID: 2879587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on agents with vasodilator and beta-blocking activities. II.
    Seki T; Takezaki T; Ohuchi R; Ohuyabu H; Tanimoto Y; Yamaguchi T; Saitoh M; Ishimori T; Yasuda K
    Chem Pharm Bull (Tokyo); 1995 Feb; 43(2):247-55. PubMed ID: 7728931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on agents with vasodilator and beta-blocking activities. IV.
    Seki T; Nakao T; Masuda T; Hasumi K; Gotanda K; Ishimori T; Honma S; Minami N; Shibata K; Yasuda K
    Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2061-9. PubMed ID: 8945771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological properties of the stereoisomers of prizidilol: their use in analysis of reflex tachycardia and blood pressure control in normotensive cats, rats, and dogs.
    Owen DA; Eden RJ; Lamb MS; Taylor EM
    J Cardiovasc Pharmacol; 1986; 8(4):743-8. PubMed ID: 2427813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acebutolol, metoprolol and propranolol in conscious dogs with chronic heart-block: chronotropic effects and relation between depression of ventricular activity and beta-adrenoceptor blocking potency.
    Boucher M; Duchene-Marullaz P
    Br J Pharmacol; 1980 Oct; 70(2):335-40. PubMed ID: 6107135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane stabilizing activity and beta-adrenoceptor antagonist-induced bradycardia in conscious dogs.
    Boucher M; Chapuy E; Duchêne-Marullaz P
    Eur J Pharmacol; 1992 Feb; 211(3):343-9. PubMed ID: 1352254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of the cardiac chronotropic effects of rilmenidine with the autonomic nervous system in conscious dogs: comparison with clonidine.
    Boucher M; Dubar M; Chapuy E; Chassaing C
    J Auton Pharmacol; 1996 Feb; 16(1):13-20. PubMed ID: 8736426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-adrenoceptor blockade and vasodilatation in essential hypertension. Hemodynamic studies at rest and during exposure to stress.
    Eggertsen R
    Acta Med Scand Suppl; 1984; 689():1-46. PubMed ID: 6151343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effects of combined vasodilation and beta-adrenoceptor blockade with prizidilol on renal function.
    Boehringer K; Weidmann P; Link L; Bianchetti MG; Schiffl H; Reubi FC
    Br J Clin Pharmacol; 1983 Feb; 15(2):181-8. PubMed ID: 6133543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prizidilol, an antihypertensive with precapillary vasodilator and beta-adrenoceptor blocking actions, in primary hypertension.
    Larsson R; Karlberg BE; Norlander B; Wirsén A
    Clin Pharmacol Ther; 1981 May; 29(5):588-93. PubMed ID: 6111409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effects of prizidilol on blood pressure, heart rate, catecholamines, renin and aldosterone in essential hypertension.
    Bianchetti MG; Boehringer K; Weidmann P; Link L; Schiffl H; Ziegler WH
    Eur J Clin Pharmacol; 1982 Oct; 23(4):289-96. PubMed ID: 6129141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of prizidilol and propranolol on renal haemodynamics at rest and during exercise.
    Malini PL; Strocchi E; Ambrosioni E
    Br J Clin Pharmacol; 1984 Mar; 17(3):251-5. PubMed ID: 6712858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological studies of N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride (MDL-899), a new long-acting antihypertensive vasodilator.
    Baldoli E; Bianchi G; Corsico N; Di Francesco GF
    Arzneimittelforschung; 1985; 35(5):818-26. PubMed ID: 2862874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.